Subamolide a induces mitotic catastrophe accompanied by apoptosis in human lung cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Hung, Jen Yu ^a,b   Wen, Ching Wen ^c   Hsu, Ya Ling ^c   Lin, En Shyh ^d   Huang, Ming Shyan ^a   Chen, Chung Yi ^e   Kuo, Po Lin ^a,f  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAICHUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e FOOYIN UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

(3,4,5) 3 TETRADECYLIDENE 4 HYDROXY 5 METHYLBUTANOLIDE; ACTIVATING TRANSCRIPTION FACTOR 3; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ATM PROTEIN; GLUTATHIONE; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; SERINE; SMALL INTERFERING RNA; SUBAMOLIDE A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL DEATH; CELL PROLIFERATION; CINNAMOMUM SUBAVENIUM; CINNAMON; COLONY FORMATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LUNG NON SMALL CELL CANCER; MALE; MITOSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; UPREGULATION;

EID: 84875491375     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/828143     Document Type: Article

References (47)

1. Demicheli R., Fornili M., Ambrogi F., Higgins K., Boyd J. A., Biganzoli E., Kelsey C. R., Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. Journal of Thoracic Oncology 2012 7 723 730
2. Siegel R., Ward E., Brawley O., Jemal A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians 2011 61 212 236
3. Provencio M., Sánchez A., Garrido P., Valcárcel F., New molecular targeted therapies integrated with radiation therapy in lung cancer. Clinical Lung Cancer 2010 11 91 97
4. Shiozaki K., Shiozaki M., Russell P., Mcs4 mitotic catastrophe suppressor regulates the fission yeast cell cycle through the Wik1-Wis1-Spc1 kinase cascade. Molecular Biology of the Cell 1997 8 3 409 419 2-s2.0-0030968066 (Pubitemid 27171291)
5. Vakifahmetoglu H., Olsson M., Zhivotovsky B., Death through a tragedy: mitotic catastrophe. Cell Death and Differentiation 2008 15 7 1153 1162 2-s2.0-45449096100 10.1038/cdd.2008.47 (Pubitemid 351850968)
6. Castedo M., Perfettini J. L., Roumier T., Andreau K., Medema R., Kroemer G., Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004 23 16 2825 2837 2-s2.0-2342635919 10.1038/sj.onc.1207528 (Pubitemid 38638845)
7. Galluzzi L., Vitale I., Abrams J. M., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2012 19 107 120
8. Eom Y. W., Kim M. A., Park S. S., Goo M. J., Kwon H. J., Sohn S., Kim W. H., Yoon G., Choi K. S., Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005 24 30 4765 4777 2-s2.0-23044467656 10.1038/sj.onc.1208627 (Pubitemid 41076294)
9. Vasquez R. J., Howell B., Yvon A. M. C., Wadsworth P., Cassimeris L., Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro. Molecular Biology of the Cell 1997 8 6 973 985 2-s2.0-0030920202 (Pubitemid 27276319)
10. Burns T. F., Fei P., Scata K. A., Dicker D. T., El-Deiry W. S., Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (Taxol)-exposed cells. Molecular and Cellular Biology 2003 23 16 5556 5571 2-s2.0-0042132030 10.1128/MCB.23.16.5556-5571.2003 (Pubitemid 36951322)
11. Galluzzi L., Vitale I., Vacchelli E., Kroemer G., Cell death signaling and anticancer therapy. Frontiers in Oncology 2011 5 1
12. Formentini L., Sánchez-Aragó M., Sánchez-Cenizo L., Cuezva J. M., The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Molecular Cell 2012 45 731 742
13. Gnocchi D., Leoni S., Incerpi S., Bruscalupi G., 3,5, 3 ′ -triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes. Steroids 2012 77 589 595
14. Hung J. Y., Hsu Y. L., Ni W. C., Tsai Y. M., Yang C. J., Kuo P. L., Huang M. S., Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells. Lung Cancer 2010 68 3 355 365 2-s2.0-77952543940 10.1016/j.lungcan.2009. 07.017
15. Han Y. H., Park W. H., The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione. Oncology Reports 2009 22 2 385 391 2-s2.0-68349109741 10.3892/or-00000449
16. Lenaz G., Mitochondria and reactive oxygen species. Which role in physiology and pathology? Advances in Experimental Medicine and Biology 2012 942 93 136
17. Kuo P. L., Chen C. Y., Hsu Y. L., Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Cancer Research 2007 67 15 7406 7420 2-s2.0-34547641948 10.1158/0008-5472.CAN-07-1089 (Pubitemid 47206571)
18. Dong L. F., Low P., Dyason J. C., Wang X. F., Prochazka L., Witting P. K., Freeman R., Swettenham E., Valis K., Liu J., Zobalova R., Turanek J., Spitz D. R., Domann F. E., Scheffler I. E., Ralph S. J., Neuzil J., -Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008 27 31 4324 4335 2-s2.0-47549092354 10.1038/onc.2008.69 (Pubitemid 352010000)
19. Makovski A., Yaffe E., Shpungin S., Nir U., Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells. Cell Signal 2012 24 1369 1374
20. Huang J., Yang J., Maity B., Mayuzumi D., Fisher R. A., Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism. Cancer Research 2011 71 6310 6319
21. Lee C. H., Kuo C. N., Chen H. L., Chen C. Y., Review on pharmacological activities of Cinnamomum subavenium. Natural Product Research 2012
22. Wang H. M., Chiu C. C., Wu P. F., Chen C. Y., Subamolide e from Cinnamomum subavenium induces sub-G1 cell-cycle arrest and caspase-dependent apoptosis and reduces the migration ability of human melanoma cells. Journal of Agricultural and Food Chemistry 2011 59 15 8187 8192 2-s2.0-79961159843 10.1021/jf2018929
23. Liu C. H., Chen C. Y., Huang A. M., Li J. H., Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. Journal of Ethnopharmacology 2011 137 503 511
24. Purvis J. E., Karhohs K. W., Mock C., Batchelor E., Loewer A., Lahav G., p53 dynamics control cell fate. Science 2012 336 1440 1444
25. Okamoto A., Iwamoto Y., Maru Y., Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Molecular and Cellular Biology 2006 26 3 1087 1097 2-s2.0-31344445155 10.1128/MCB.26.3. 1087-1097.2006 (Pubitemid 43146500)
26. Taketani K., Kawauchi J., Tanaka-Okamoto M., Ishizaki H., Tanaka Y., Sakai T., Miyoshi J., Maehara Y., Kitajima S., Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene 2012 31 2210 2221
27. Chang A., Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 2011 71 1 3 10 2-s2.0-78650236850 10.1016/j.lungcan.2010.08.022
28. Vitale I., Galluzzi L., Castedo M., Kroemer G., Mitotic catastrophe: a mechanism for avoiding genomic instability. Nature Reviews Molecular Cell Biology 2011 12 385 392
29. Huertas D., Soler M., Moreto J., Villanueva A., Martinez A., Vidal A., Charlton M., Moffat D., Patel S., McDermott J., Owen J., Brotherton D., Krige D., Cuthill S., Esteller M., Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin. Oncogene 2012 31 1408 1418
30. Jiang L., Siu M. K., Wong O. G., Tam K. F., Lu X., Lam E. W., Ngan H. Y., Le X. F., Wong E. S., Monteiro L. J., Chan H. Y., Cheung A. N., iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. Clinical Cancer Research 2011 17 6924 6933
31. Nitta M., Kobayashi O., Honda S., Hirota T., Kuninaka S., Marumoto T., Ushio Y., Saya H., Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004 23 39 6548 6558 2-s2.0-4444245817 10.1038/sj.onc.1207873 (Pubitemid 39265518)
32. Cerna D., Li H., Flaherty S., Takebe N., Coleman C. N., Yoo S. S., Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner. Journal of Biological Chemistry 2012 287 22408 22417
33. Piccirillo S., Filomeni G., Brüne B., Rotilio G., Ciriolo M. R., Redox mechanisms involved in the selective activation of Nrf2-mediated resistance versus p53-dependent apoptosis in adenocarcinoma cells. Journal of Biological Chemistry 2009 284 40 27721 27733 2-s2.0-70350068501 10.1074/jbc.M109.014837
34. Kigawa J., Minagawa Y., Cheng X., Terakawa N., γ -glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer. Clinical Cancer Research 1998 4 7 1737 1741 2-s2.0-0031745799 (Pubitemid 28304736)
35. Tamada M., Nagano O., Tateyama S., Ohmura M., Yae T., Ishimoto T., Sugihara E., Onishi N., Yamamoto T., Yanagawa H., Suematsu M., Saya H., Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Research 2012 72 1438 1448
36. Berdelle N., Nikolova T., Quiros S., Efferth T., Kaina B., Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Molecular Cancer Therapeutics 2011 10 2224 2233
37. Imreh G., Norberg H. V., Imreh S., Zhivotovsky B., Chromosomal breaks during mitotic catastrophe trigger γ H2AX-ATM-p53-mediated apoptosis. Journal of Cell Science 2011 124 2951 2963
38. Zhao H., Traganos F., Darzynkiewicz Z., Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Cell Cycle 2008 7 19 3048 3055 2-s2.0-53649106518
39. Das K. C., Dashnamoorthy R., Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites. American Journal of Physiology 2004 286 1 L87 L97 2-s2.0-0347357996 (Pubitemid 38055862)
40. Gonçalves A. P., Máximo V., Lima J., Singh K. K., Soares P., Videira A., Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochimica et Biophysica Acta 2011 1813 3 492 499 2-s2.0-79951906204 10.1016/j.bbamcr.2011.01.006
41. Chen B. P. C., Wolfgang C. D., Hai T., Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Molecular and Cellular Biology 1996 16 3 1157 1168 2-s2.0-0030026565 (Pubitemid 26061687)
42. Gilchrist M., Henderson W. R. Jr., Morotti A., Johnson C. D., Nachman A., Schmitz F., Smith K. D., Aderem A., A key role for ATF3 in regulating mast cell survival and mediator release. Blood 2010 115 23 4734 4741 2-s2.0-77954725233 10.1182/blood-2009-03-213512
43. Kwon O., Soung N. K., Thimmegowda N. R., Jeong S. J., Jang J. H., Moon D. O., Chung J. K., Lee K. S., Kwon Y. T., Erikson R. L., Ahn J. S., Kim B. Y., Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation. Cell Signal 2012 24 943 950
44. Gurzov E. N., Barthson J., Marhfour I., Ortis F., Naamane N., Igoillo-Esteve M., Gysemans C., Mathieu C., Kitajima S., Marchetti P., Ørntoft T. F., Bakiri L., Wagner E. F., Eizirik D. L., Pancreatic β -cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene 2012 31 1723 1732
45. Bandyopadhyay S., Wang Y., Zhan R., Pai S. K., Watabe M., Iiizumi M., Furuta E., Mohinta S., Liu W., Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., Commes T., Piquemal D., Hai T., Watabe K., The tumor metastasis suppressor gene Drg-1down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Research 2006 66 11983 11990 (Pubitemid 46094212)
46. Germain C. S., Niknejad N., Ma L., Garbui K., Hai T., Dimitroulakos J., Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3. Neoplasia 2010 12 7 527 538 2-s2.0-77954998365 10.1593/neo.92048
47. Wang H., Mo P., Ren S., Yan C., Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6. Journal of Biological Chemistry 2010 285 17 13201 13210 2-s2.0-77951223217 10.1074/jbc.M109.058669